Drugs Made In America Acquisition Corp. (DMAA)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 67
+0.02
+0.1878%
$
359.42M Market Cap
- P/E Ratio
- Div Yield
800 Volume
- Eps
$ 10.65
Previous Close 
Want to track DMAA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition Corp. (DMAA) Statistics
Valuation metrics
Market Cap 359.42M
Enterprise value 359.85M
Trailing P/E (ttm) 52.15
Forward P/E -
PEG ratio -0.52
Price/Sales (ttm) -
Price/Book (mrq) 1.05
Enterprise Value/Revenue -
Enterprise Value/EBITDA -136.91
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 811
Average volume (90 days) 73.31K
Price summary
52-Week low 10.22
52-Week high 10.69
Beta -
50-Day moving average 10.64
200-Day moving average 10.49
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 0.03%
Book value per share (mrq) 10.2
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
